Our results strongly suggest that in breast cancer, ΔNp63, by physically interacting with SETDB1, could redirect SETDB1 to specific genomic regions and therefore alter H3K9me3 mark responsible for chromatin modification and gene silencing. The gene discussed is SETDB1; the disease is breast cancer.